Edges in Network
| Network | GSE12093_egf1520 - GSE12093 - SiGN-BN HC+Bootstrap |
| Network Description | The 76-gene Signature Defines High-Risk Patients that Benefit from Adjuvant Tamoxifen Therapy |
| Node | DVL1 |
| Upstream (Parents) |
|---|
| (<<) BZW1 → DVL1 |
| (<<) DAZAP2 → DVL1 |
| (<<) EIF4E → DVL1 |
| (<<) GLTPD1 → DVL1 |
| (<<) GNB2L1 → DVL1 |
| (<<) MAN2A2 → DVL1 |
| (<<) MAPK1 → DVL1 |
| (<<) MAT2A → DVL1 |
| (<<) NFKB2 → DVL1 |
| (<<) PPIF → DVL1 |
| (<<) SMARCC2 → DVL1 |
| (<<) TYK2 → DVL1 |
| (<<) YWHAH → DVL1 |
| (<<) ZNF205 → DVL1 |
| Downstream (Children) |
|---|
| DVL1 → B3GNT2 (>>) |
| DVL1 → CAV3 (>>) |
| DVL1 → CLK3 (>>) |
| DVL1 → CSNK1E (>>) |
| DVL1 → EFNB1 (>>) |
| DVL1 → ENO3 (>>) |
| DVL1 → FZD1 (>>) |
| DVL1 → GLRX (>>) |
| DVL1 → GOT2 (>>) |
| DVL1 → GRB10 (>>) |
| DVL1 → HMOX1 (>>) |
| DVL1 → MAP3K3 (>>) |
| DVL1 → MAP3K6 (>>) |
| DVL1 → MAPK11 (>>) |
| DVL1 → MEX3D (>>) |
| DVL1 → MKNK2 (>>) |
| DVL1 → MYO10 (>>) |
| DVL1 → NFIB (>>) |
| DVL1 → NRAS (>>) |
| DVL1 → PALM (>>) |
| DVL1 → PI3 (>>) |
| DVL1 → PPP2R5B (>>) |
| DVL1 → PPRC1 (>>) |
| DVL1 → PRKCI (>>) |
| DVL1 → PRKCZ (>>) |
| DVL1 → RHBDL1 (>>) |
| DVL1 → RPS6KA1 (>>) |
| DVL1 → SF3A2 (>>) |
| DVL1 → SHFM1 (>>) |
| DVL1 → SPPL2B (>>) |
| DVL1 → STK16 (>>) |
| DVL1 → TCEAL1 (>>) |
| DVL1 → TMEM39B (>>) |
| DVL1 → UBE2J1 (>>) |
| DVL1 → WNT5B (>>) |
| DVL1 → YWHAQ (>>) |
